BioControl Medical has announced that the pilot clinical study of its CardioFit vagus nerve stimulation system has been recognized as seminal original research in the European Journal of Heart Failure. According to a recent editorial, “the highly cited open-label Phase II study [of the CardioFit] by De Ferrari et al. demonstrated for the first time that chronic vagus nerve stimulation is associated with improvements in New York Heart Association (NYHA) class, six min[ute] walk test, left ventricular ejection fraction, and systolic volumes up to 1 year, [setting] the stage for further investigations and clinical trials in this new era of device thearapy.”[1,2]
Hospitalized children who suffer cardiac arrest are nearly three times more likely to survive than they were about a decade ago, and no more likely to suffer brain impairment, according to new research in the American Heart Association journal Circulation: Cardiovascular Quality & Outcomes.
December 19, 2012 — The latest generation of diagnostic tests in development is expected to provide information that will be important to patient outcomes, potentially reducing the time to diagnosis of heart attacks by several hours. The specific performance characteristics of several troponin tests were evaluated in a new study published in Clinical Chemistry.[1]
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 19, 2012 — CardiacAssist Inc. announced it has received investigational device exemption (IDE) approval from the U.S. Food & Drug Administration (FDA) for a pivotal clinical study of the TandemHeart circulatory support system. The TandemHeart to Reduce Infarct Size (TRIS) trial will evaluate the effectiveness of ventricular unloading on the reduction of infarct size for patients who have suffered a severe heart attack.
DAIC Editor Dave Fornell highlights the latest advancements that will impact cardiovascular imaging from the 2012 ...
December 18, 2012 — Zoll Medical Corp. announced that its new U.S. Food and Drug Administration (FDA)-cleared OneStep pediatric CPR electrodes are the only electrodes on the market with a built-in sensor that reports CPR quality on young children up to 8 years of age.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
BioControl Medical has announced that the pilot clinical study of its CardioFit vagus nerve stimulation system has been recognized as seminal original research in the European Journal of Heart Failure. According to a recent editorial, “the highly cited open-label Phase II study [of the CardioFit] by De Ferrari et al. demonstrated for the first time that chronic vagus nerve stimulation is associated with improvements in New York Heart Association (NYHA) class.”
For functional mitral valve regurgitation, the results of open repair are poor, but the next generation of transcatheter heart valve repair technologies in development may offer new hope for these patients.
As mobile devices become more integrated into the healthcare workflow, immediate anywhere access to ECGs can help improve collaboration and speed door-to-balloon times. Physician smart phone and tablet PC use has exploded over the last few years, allowing widespread, immediate access to patient electronic medical record (EMR) information. One trend in cardiology is the ability to use this technology to immediately view dynamic electrocardiogram (ECG) waveforms anywhere, untethering them from hospital workstations.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Abiomed Inc. announced the U.S. Food and Drug Administration's (FDA) Circulatory System Devices Panel voted to retain Class III status for the temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category, which includes Impella.
DAIC is seeking readers’ nominations for state-of-the-art cardiac departments and heart centers based on their use of cutting-edge technology. Key factors to be considered include how new technologies are being used to help improve patient outcomes, increase efficiency, reduce costs, increase patient volume, or increase reimbursements/revenues.
More than a million adult congenital heart disease patients in the United States will soon be able to choose a specialist who has demonstrated the unique knowledge and skills their care requires thanks to a new subspecialty certification for adult congenital heart disease.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 14, 2012 — KLAS has released the 2012 Best in KLAS Awards: Software and Services report ranking the best performing healthcare IT vendors in just under 100 market segments. This year, nearly 20,000 provider interviews led to a mix of newly crowned and repeat Best in KLAS winners.
December 13, 2012 — St. Jude Medical Inc. announced the first patient implant of its 23 mm Portico transcatheter aortic heart valve using the transapical delivery system.
December 13, 2012 — CardioNet Inc. announced the release of a new application for the iPad, designed to provide physicians and their support staff easy access to the cardiac monitoring services at CardioNet.